Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

8 results about "Lung cancer" patented technology

Cancer which begins in the cells of the lung.

Serum specificity metabolite spectrum for patient with lung cancer, and building method thereof

ActiveCN103616450AEasy to handleStrong qualitative analysis abilityComponent separationGas phaseOriginal data
The invention discloses a serum specificity metabolite spectrum for a patient with a lung cancer and a building method thereof, and particularly discloses a method for carrying out liquid-phase/gas-phase chromatography mass spectrometry metabonomics analysis based on the patient suffering from the lung cancer. The method comprises the following steps: collecting fasting blood samples of a healthy and normal detected person and the patient suffering from the lung cancer 7 days before and after an operation, separating by a chromatogram column after processing; extracting and aligning original data of an instrument after adopting mass spectrometry analysis; building a mathematical model to analyze the metabolites spectrum by adopting multivariable data statistical software; comparing with the difference between an average person with the metabolites spectrum of the patient with the lung cancer, so as to determine the specificity metabolite spectrum. By adopting the method disclosed by the invention, the mutation status of the metabolite of the patient with the lung cancer can be generally and comprehensively reflected, and the serum specificity metabolite spectrum can be applied to early diagnosis of the lung cancer or a beneficial technical support is supplied for prognosis.
Owner:HUZHOU CENT HOSPITAL

Thioredoxin reductase inhibiter compounds and preparation method and application thereof

ActiveCN101781283AOrganic chemistryAntineoplastic agentsMelanomaProstate cancer
The invention discloses thioredoxin reductase inhibiter compounds, which have antitumor activity, particularly have growth inhibition activity for solid tumor, wherein the solid tumor is thyroid cancer, prostatic cancer, colon cancer, rectal cancer, melanoma, liver cancer, lung cancer, gastric cancer, carcinoma submaxilary gland, nasopharyngeal darcinoma or breast cancer.
Owner:KEAISE MEDICINE WUHAN

Lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and preparation method of lung cancer and breast cancer compound preparation

InactiveCN105079005AGood inhibitory effectHigh anticancer activityEther/acetal active ingredientsRespiratory disorderPolyethylene glycolIn vivo
The invention discloses a lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and a preparation method of the lung cancer and breast cancer compound preparation. The lung cancer and breast cancer treatment compound preparation is made from erianin, taxol, bufalin and bruceine D according to a certain weight ratio. According to the preparation method, liposomes are prepared according to an ethyl alcohol injection method or dropping pills are prepared by taking polyethylene glycol as a base material to obtain the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine. The form of the compound preparation is compound liposomes and compound dripping pills. According to animal in-vivo anticancer pharmacological experiments, the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine has obvious inhibiting effect on growth of lung cancer and breast cancer and has higher anticancer activity than chemotherapeutic drug 5-fluorouracil.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Saponins antineoplastic compound in Bohadschia argus Jaeger

InactiveCN101085805AOrganic active ingredientsSteroidsChemical structureResource utilization
The invention relates to medical technique, which in detail relates to a saponin antineoplastic compound Arguside B or Arguside C. The R1 in structure general formula represents OH or H, R2 represents CH3 or CH2OH, when R1 is OH and R2 is CH3, the compound is Arguside B; when R1 is H and R2 is CH2OH, the compound is Arguside C. The chemical structure and spatial configuration of said two compounds are determined through various modern spectral analysises, especially through analysis with multiple advanced nuclear magnetic resonance spectroscopy. It is tested that said two compounds are apparently inhibitive to seven cancers such as A- 549 lung cancer and MCF- 7 breast cancer. It can be used to prepare antineoplastic medicine. The invention provides leading compound for new antineoplastic medicine development, and is valuable for ocean biological resource utilization in China.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Wild ganoderma product for resisting cancer and tumor and removing liver toxin and preparation technology

InactiveCN108968031AGood anti-corrosion and fresh-keeping effectStrengthen cancer treatmentFruit and vegetables preservationFood ingredient functionsDiseaseNasopharyngeal carcinoma
The invention discloses a wild ganoderma product for resisting cancer and tumor and removing liver toxin and a preparation technology. According to the invention, wild ganoderma lucidum is adopted asraw material, and the wild ganoderma product for resisting cancer and tumor and removing liver toxin is finally prepared by the steps of washing, sterilizing, drying and dicing and the like. The product has the advantages of inhibiting cancer cell growth, attending acute and chronic hepatitis, early cirrhosis, esophageal cancer, lung cancer, liver cancer, nasopharyngeal carcinoma, pancreatic cancer, neurasthenia, intestinal diarrhea, rheumatoid tuberculosis,diabetes, gastrointestinal diseases, nourishing physical, lowering blood sugar, moistening the lungs and kidneys, maintaining beauty and keeping young, enhancing immunity, and enriches in ergosterol, ganoderic acid, ganoderma lucidum polysaccharides, amino acids, polypeptides, adenosine, triterpenoids and various trace elements, whereinthe organic germanium content is as high as 12380 ppm and the organic selenium content is also high. The product can be made into five-color ganoderma lucidum tea, ganoderma lucidum beverage, ganoderma lucidum oral liquid, five-color ganoderma lucidum wine, and other homologous products of medicines and foods. The product provided by the invention can also be made into traditional Chinese medicine prescriptions such as paste, pill and pellet.
Owner:深圳玺越建材科技有限公司

Biological detection kit for lung cancer

InactiveCN109229917AShock-sensitive articlesLung cancerEngineering
The invention discloses a biological detection kit for lung cancer, which comprises a box body, wherein the box body is divided into a heat preservation part and a normal temperature part, and a refrigeration device is arranged in the heat preservation part to provide a cooling environment for the heat preservation environment. Temperature conducting materials are evenly disposed in the heat preservation part, and the temperature conducting materials are disposed around the receiving hole for placing a reagent bottle. The refrigeration device provides a low temperature environment for the reagent bottle in the receiving hole through the temperature conducting material. The refrigeration device is connected to a microprocessor, and the microprocessor is connected to a temperature sensor. The temperature sensor is used for collecting temperature data within the heat preservation part, and the microprocessor is used for controlling the operation of the refrigeration device based on the temperature data. The biological detection kit for lung cancer has the advantages that the refrigeration conducting of the refrigeration device is transmitted to the reagent bottle by using the temperature conducting material, the purpose of uniformly cooling the reagent bottle can be achieved, the partial cooling caused by the direct contact is reduced, and the cooling and preservation effect of the reagent is affected, so that the kit is convenient and reliable for storage and transportation.
Owner:安徽健朗医疗器械有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products